Last quarter (Q4 2023), Pediatrix Medical Group's total revenue was $496.44M, an increase of Infinity% from the same quarter last year. In Q4, Pediatrix Medical Group's net income was $-2.48B. See Pediatrix Medical Group’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 1.99B	$ 1.99B	$ 1.97B	$ 1.91B	$ 1.73B	$ 1.78B
Cost of Revenue	-	-	-	-	$ 1.28B	$ 1.28B
Gross Profit	$ 1.50B	$ 1.99B	-	-	$ 449.32M	$ 503.09M
Operating Expense	$ 1.99B	$ 1.99B	$ -1.80B	$ -1.71B	$ 277.39M	$ 270.44M
Operating Income	$ 286.56M	$ 7.32M	$ -1.77B	$ -1.69B	$ 171.93M	$ 232.65M
Net Non Operating Interest Income Expense	$ -40.25M	$ -42.08M	$ -36.02M	$ -55.07M	$ -110.48M	$ -118.93M
Other Income Expense	$ -497.10M	$ -7.92M	$ -1.91B	$ -1.89B	$ -54.30M	$ -54.93M
Pretax Income	$ -48.36M	$ -48.36M	$ 81.37M	$ 135.23M	$ 7.15M	$ 58.78M
Tax Provision	$ 12.05M	$ 12.05M	$ 18.81M	$ 27.24M	$ 16.73M	$ 16.58M
Earnings From Equity Interest Net Of Tax	$ 2.06M	$ 2.06M	$ 1.72M	$ 1.91M	-	-
Net Income Common Stockholders	$ -1.62B	$ -60.41M	$ 61.28M	$ 114.19M	$ -796.49M	$ -1.50B
Basic EPS	-	-	-	-	-	-
Diluted EPS	-	-	-	-	-	-
Basic Average Shares	-	-	-	-	-	-
Diluted Average Shares	-	-	-	-	-	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 1.71B	$ 1.99B	$ -1.80B	$ -1.71B	$ 1.56B	$ 1.55B
Net Income From Continuing And Discontinued Operation	$ -60.41M	$ -60.41M	$ 61.28M	$ 114.19M	$ -796.49M	$ -1.50B
Normalized Income	$ 55.13M	$ 132.32M	-	-	$ 31.22M	$ 83.29M
Interest Expense	-	-	-	-	$ 110.48M	$ 118.93M
EBIT	$ 122.48M	$ -6.28M	$ 121.06M	$ 203.95M	$ 117.63M	$ 177.71M
EBITDA	$ 150.61M	$ 31.13M	$ 158.47M	$ 240.43M	$ 146.07M	$ 203.64M

Currency in USD

Pediatrix Medical Group Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing